Posts Tagged ‘PG’

Running The Numbers - Colgate-Palmolive ($CL) Intrinsic Valuation

Tuesday, November 11th, 2008

At Valuecruncher we have previously looked at Procter & Gamble ($PG). Competitor Colgate Palmolive ($CL) announced strong Q3 results at the end of October. $CL is trading close to a 52-week low at US$63.55. So how does the current share price of $CL look from an intrinsic value perspective?

Valuecruncher valuation model of $CL with interactive assumptions

Valuecruncher produces a valuation of US$75.96 for $CL. This is a current valuation (an estimate of intrinsic value using a discounted cash flow model) not a target price. This valuation is 19.5% above the current share price of US$58.76.

Assumptions

  • Revenue: Reuters aggregates 12 analysts covering $CL and these analysts have mean estimates of 2008 and 2009 revenues of US$15.7 billion and US$16.8 billion respectively. For our analysis we have used US$15.5 billion in 2008, US$16.5 billion in 2009 and US$17.5 billion in 2010.
  • Profitability: We have used a flat EBITDA margin of 22.0% to 2010. Reuters has $CL‘s EBITD margin at 21.5% last year and 22.9% over the last five-years.
  • Capital Expenditure: We have assumed capital expenditures of US$600.0 million per annum moving forward.
  • Discount Rate: 8.0%.
  • Terminal Growth Rate: 3.0%.

Our analysis incorporates the cash and debt the $CL balance sheet – Valuecruncher calculates a net debt number.

Play with our assumptions – what does your analysis say?

Disclosure: None

More on this topic (What's this?)
Colgate-Palmolive (CL) Dividend Stock Analysis
Stock Analysis: Colgate Palmolive (CL)
Read more on Colgate-Palmolive Company at Wikinvest

Running The Numbers - Procter & Gamble ($PG)

Wednesday, October 22nd, 2008

Proctor & Gamble ($PG) is trading close to a 52-week low at US$58.76.  We decided to run some numbers around the branded consumer goods company.

Valuecruncher valuation model of $PG with interactive assumptions

Valuecruncher produces a valuation of US$72.92 for $PG. This is a current valuation (an estimate of intrinsic value using a discounted cash flow model) not a target price. This valuation is 24.1% above the current share price of US$58.76.

Assumptions

  • RevenueReuters aggregates 13analysts covering $PG and these analysts have mean estimates of  2009 revenues of US$88.4 billion. For our analysis we have used US$87.0 billion in 2009, US$91.0 billion in 2010 and US$94.5 billion in 2011.
  • Profitability: We have used an EBITDA margin of 23.0% in 2009 rising to 24.0% in 2011. Reuters has $PG‘s EBITD margin at 24.5% last year and 23.5% over the last five-years.
  • Capital Expenditure: We have assumed capital expenditures of US$3.5 billion in 2009 and 2010 rising to US$3.75 billion in 2011 and US$3.5 billion beyond that.
  • Discount Rate: 8.0%.
  • Terminal Growth Rate: 3.0%.

Our analysis incorporates the cash and debt the $PG balance sheet – Valuecruncher calculates a net debt number.

Play with our assumptions – what does your analysis say?

Disclosure: None

More on this topic (What's this?)
Procter & Gamble, Folgers, and Smuckers
Procter & Gamble (PG) Dividend Stock Analysis
Read more on Procter & Gamble Company at Wikinvest

Subscribe

Categories